Bank of America
RYTM icon

Bank of America’s Rhythm Pharmaceuticals RYTM Stock Holding History

Bank of America’s Portfolio RYTM Stock Details RYTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$36.1M Sell
325,470
-303,197
-48% -$27.4M ﹤0.01% 1974
2026
Q1 		$54.7M Buy
628,667
+404,183
+180% +$39.3M ﹤0.01% 1523
2025
Q4 		$24M Sell
224,484
-8,666
-4% -$919K ﹤0.01% 2132
2025
Q3 		$23.5M Buy
233,150
+10,998
+5% +$1.02M ﹤0.01% 2468
2025
Q2 		$14M Buy
222,152
+110,400
+99% +$6.76M ﹤0.01% 2901
2025
Q1 		$5.92M Buy
111,752
+7,264
+7% +$403K ﹤0.01% 3648
2024
Q4 		$5.85M Sell
104,488
-1,762
-2% -$97.3K ﹤0.01% 3439
2024
Q3 		$5.57M Buy
106,250
+14,207
+15% +$681K ﹤0.01% 3643
2024
Q2 		$3.78M Sell
92,043
-19,071
-17% -$761K ﹤0.01% 3885
2024
Q1 		$4.81M Buy
111,114
+41,244
+59% +$1.8M ﹤0.01% 3648
2023
Q4 		$3.21M Sell
69,870
-40,373
-37% -$1.27M ﹤0.01% 3937
2023
Q3 		$2.53M Sell
110,243
-29,875
-21% -$669K ﹤0.01% 4044
2023
Q2 		$2.31M Sell
140,118
-219,548
-61% -$3.96M ﹤0.01% 4098
2023
Q1 		$6.42M Buy
359,666
+93,513
+35% +$2.35M ﹤0.01% 3285
2022
Q4 		$7.75M Buy
266,153
+47,744
+22% +$1.23M ﹤0.01% 2933
2022
Q3 		$5.35M Buy
218,409
+169,297
+345% +$3.15M ﹤0.01% 3283
2022
Q2 		$203K Buy
49,112
+9,497
+24% +$52K ﹤0.01% 6079
2022
Q1 		$457K Sell
39,615
-83,020
-68% -$729K ﹤0.01% 5901
2021
Q4 		$1.22M Sell
122,635
-81,828
-40% -$919K ﹤0.01% 5036
2021
Q3 		$2.67M Buy
204,463
+84,785
+71% +$1.29M ﹤0.01% 4174
2021
Q2 		$2.34M Buy
119,678
+13,236
+12% +$275K ﹤0.01% 4199
2021
Q1 		$2.26M Buy
106,442
+16,283
+18% +$472K ﹤0.01% 4155
2020
Q4 		$2.68M Sell
90,159
-188,221
-68% -$4.78M ﹤0.01% 3691
2020
Q3 		$6.03M Buy
278,380
+22,222
+9% +$509K ﹤0.01% 2737
2020
Q2 		$5.71M Buy
256,158
+209,649
+451% +$4.09M ﹤0.01% 2721
2020
Q1 		$708K Sell
46,509
-3,551
-7% -$63.6K ﹤0.01% 4260
2019
Q4 		$1.15M Buy
50,060
+14,604
+41% +$324K ﹤0.01% 4405
2019
Q3 		$765K Buy
35,456
+8,823
+33% +$189K ﹤0.01% 4755
2019
Q2 		$586K Buy
26,633
+6,871
+35% +$174K ﹤0.01% 4949
2019
Q1 		$541K Sell
19,762
-6,434
-25% -$185K ﹤0.01% 4960
2018
Q4 		$704K Buy
26,196
+14,085
+116% +$389K ﹤0.01% 4689
2018
Q3 		$354K Buy
12,111
+5,860
+94% +$185K ﹤0.01% 5166
2018
Q2 		$195K Buy
6,251
+3,282
+111% +$89.7K ﹤0.01% 5427
2018
Q1 		$59K Sell
2,969
-733
-20% -$19.5K ﹤0.01% 5972
2017
Q4 		$107K Buy
+3,702
New +$97.9K ﹤0.01% 5712

Other funds holding RYTM

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Bank of America's RYTM Position: Q2 2026 in Review

Bank of America reduced its Rhythm Pharmaceuticals (RYTM) stake by 48% in Q2 2026, selling an estimated $27.4M and leaving 325,470 shares worth $36.1M. The position accounts for ﹤0.01% of the portfolio, ranked #1974.

Bank of America first reported a position in RYTM in Q4 2017 and has held it in 35 quarters since. The position peaked at $54.7M in Q1 2026. 302 funds tracked by Wall St. Rank hold RYTM as of Q2 2026.

  • Bank of America held 325,470 shares of Rhythm Pharmaceuticals worth $36.1M as of Q2 2026.
  • Bank of America sold 303,197 Rhythm Pharmaceuticals shares in Q2 2026, an estimated $27.4M.
  • Rhythm Pharmaceuticals made up ﹤0.01% of Bank of America's portfolio in Q2 2026, its #1974 holding.
  • Bank of America first reported a position in Rhythm Pharmaceuticals in Q4 2017 and has held it in 35 quarters since.
  • Bank of America's Rhythm Pharmaceuticals position peaked at $54.7M in Q1 2026.
  • 302 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q2 2026.

Based on Bank of America's 13F filing for Q2 2026, filed 14 Aug 2026.